Working alliance and its relationship to outcomes in a randomized controlled trial (RCT) of antipsychotic medication
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Working alliance and its relationship to outcomes in a randomized controlled trial (RCT) of antipsychotic medication ; volume:13 ; number:1 ; day:15 ; month:1 ; year:2013 ; pages:1-7 ; date:12.2013
BMC psychiatry ; 13, Heft 1 (15.1.2013), 1-7, 12.2013
- Urheber
-
Wykes, Til
- Beteiligte Personen und Organisationen
-
Rose, Diana
Williams, Paul
David, Anthony S.
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-13-28
- URN
-
urn:nbn:de:1111-2016081322744
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wykes, Til
- Rose, Diana
- Williams, Paul
- David, Anthony S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Association Between Antipsychotic Medication Use and Diabetes
The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
Antipsychotic medication use and fracture: a case–control study
An explorative study of school performance and antipsychotic medication
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
The role of pharmacists in supporting service users to optimise antipsychotic medication
Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study
Changes in Antipsychotic Medication Adherence Among Medicaid Beneficiaries with Schizophrenia During COVID-19
Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication
One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication
Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selection
Association Between Antipsychotic Medication Use and Diabetes
The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
Antipsychotic medication use and fracture: a case–control study
An explorative study of school performance and antipsychotic medication
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
The role of pharmacists in supporting service users to optimise antipsychotic medication
Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study
Changes in Antipsychotic Medication Adherence Among Medicaid Beneficiaries with Schizophrenia During COVID-19
Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication
One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication
Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selection
Association Between Antipsychotic Medication Use and Diabetes
The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
Antipsychotic medication use and fracture: a case–control study
An explorative study of school performance and antipsychotic medication
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
The role of pharmacists in supporting service users to optimise antipsychotic medication
Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study
Changes in Antipsychotic Medication Adherence Among Medicaid Beneficiaries with Schizophrenia During COVID-19
Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication
One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication